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]'he involvement of the small GTP-binding protein rab3A in synaptic transmission was tested by presynaptic microinjection of guanine nucleotides 
and peptides corresponding to the effector domain of rab3A. When GTPyS injection was paired with presynaptic action potentials, the frequency 
of MIPSCs was increased and the evoked synaptic urrent was reduced in magnitude. To more specifically manipulate rab proteins, peptides were 
microinjected. Injection of the peptide rab3AL(33~8) or rab3(29~8) stimulated an increase in the frequency of MIPSC with little effect on action 
potential evoked synaptic transmission supporting a role for rab proteins in regulating synaptic transmission. 
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1. INTRODUCTION 
Small GTP-binding proteins play critical roles in vec- 
torial membrane transport between cellular compart- 
ments [1,2]. The small GTP-binding protein rab3A has 
emerged as a candidate in the regulation of vectorial 
transport of synaptic vesicles from a vesicle storage pool 
to docking sites at the plasma membrane in the nerve 
terminal [14]. Rab3A, which is found exclusively in 
secretory cells, is associated with synaptic vesicles [5,6]. 
In addition to its critical localization in the synapse, 
rab3A dissociates from the vesicular membrane follow- 
ing potassium-induced depolarization of synaptosomes 
[5]. Rab3A-GDP binds to a GDP dissociation i hibitor 
(GDI) which promotes the separation of rab3A from 
the vesicular membrane [7]. Thus, rab3A associates and 
dissociates from synaptic vesicles during synaptic trans- 
mission indicating that it may play a regulatory role in 
this process. 
Previous tudies have probed the role of GTP-bind- 
ing proteins in synaptic transmission through the micro- 
injection of guanine nucleotide analogs [8-10]. Presyn- 
aptic microinjection of non-selective G protein activa- 
tors, such as the non-hydrolyzable analog of GTP, 
GTPyS, resulted in reduced action potential-evoked 
synaptic transmission. However, since GTPTS is likely 
to activate many GTP-binding proteins these data have 
to be interpreted with caution. Using giant synapses 
which form between contacting somata of cell-cultured 
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neurons we have compared the effects of GTPyS with 
more selective probes for rab protein involvement, spe- 
cifically, peptides corresponding to the putative ffector 
domain of rab3A [11]. This latter approach as been 
used successfully to demonstrate that synthetic peptides 
of the rab3A effector domain inhibit ER to Golgi and 
intra-Golgi transport [11]. Rab3A peptides have also 
been shown to stimulate secretion in mast cells [12], 
pancreatic acini [13], and chromaffin cells [14]. In this 
study we demonstrate that microinjection of both 
GTPyS and rab peptides into neurons increase the 
spontaneous frequency of miniature synaptic urrents. 
In contrast, rab peptides have no significant effects on 
action potential-evoked release of neurotransmitter in 
the same synapses. These data provide experimental 
support for the hypothesis that rab GTP-binding pro- 
teins play regulatory roles in the synapse. Some of this 
work has appeared in preliminary form [15]. 
2. MATERIALS AND METHODS 
Cultured neurons were obtained from adult specimens of the albino 
snail Helisoma trivolvis. Identified neurons B5 and VD4 were isolated 
from the buccal and visceral ganglia, respectively, according to previ- 
ously published techniques [8,16,17]. In brief, the central ganglia were 
removed from the animal, incubated for 15 min at room temperature 
in 0.2% trypsin (Sigma type IlI) in defined medium (DM; 50% Liebow- 
itz-15 (L-15-Gibco) with additional Helisoma salts; [16]). Neurons 
were removed from the ganglia by applying suction to a heat-polished 
macropipette. Pairs of neurons B5 and VD4 were plated in culture and 
maneuvered together to allow adhesion of cell bodies using positive 
pressure from the transfer macropipette. Typically four neuron pairs 
were plated in each Falcon # 1008 plastic Petri dish within a 75 ml 
drop of conditioned medium (CM; [16]) to which 5/A of Helisoma 
blood extract was added. Blood collected from donor snails was cen- 
trifuged at 45,000 rpm for 90 min. Following centrifugation the upper 
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clear layer of the blood sample was decanted leaving a viscous red 
blood extract which was stored at -70°C prior to use. Synaptic pairs 
were left in these culture conditions for two days without exchanging 
medium. After two days cell pairs were transferred to a recording 
chamber consisting of a # 1008 Petri dish in which a poly-L-lysine 
treated coverslip had been attached to the hollowed out base. Under 
these conditions the neuronal somata dhere to the glass coverslip and 
become immobilized which is necessary for electrophysiological and 
fluorescent examination. 
2.1. PresTnaptic intracellular recordings 
Presynaptic neuron B5 was penetrated with an intracellular glass 
fiber-filled microelectrode which served to monitor and control the 
neuronal activity of B5 and to microinject test solutions. The electro- 
physiology of B5 was monitored using a Dagan 8800 amplifier and 
stored on VHS tape using a Vetter PCM video recorder. When neces- 
sary a hyperpolarizing current bias was applied to B5 to prevent 
spontaneous firing. In experiments where action potentials were re- 
quired, neuron B5 was stimulated to produce one action potential 
every 30 s using either UMANS software (Chester M. Regan, Urbana, 
IL) when simultaneous fluorescence measurements were taken, or 
through pClamp software (Axon Instruments, CA). 
2.2. Postsynaptic voltage clamp 
Postsynaptic neuron VD4 was whole-cell voltage clamped using a 
patch pipette with a DC resistance of 1 2 MY via an Axopatch-lC 
(Axon Instruments, CA). The postsynaptic pipette solution consisted 
of (in mM): 50 KCI, 5 MgCI2, 5 EGTA and 5 K+-HEPES at pH 7.3. 
Neuron VD4 was voltage clamped at a holding potential of -80 mV. 
At this potential and with the inclusion of 50 mM KC1, postsynaptic 
events in neuron VD4 are seen as inward currents. Synaptic urrents 
were monitored in neuron VD4 and stored on VHS tape using the 
Vetter PCM video recorder. MIPSCs were counted in 30 s time bins 
to obtain measures of MIPSC frequency. In all experiments a 3 min 
recording period was monitored prior to microinjection. Cell pairs 
exhibiting an average MIPSC frequency of < 2 min -t during the pre- 
test period were discounted. If the MIPSC frequency in the first 30 s 
bin following microinjection was 2 times or greater the pretest average 
M IPSC frequency, these cell pairs were rejected since this reflected cell 
damage due to injection. 
2.3. Presynaptie injections 
Microinjections of B5 were performed using a Narishige 1M-200 
(Narishige USA, Inc.). The presynaptic microelectrode was filled with 
the test solution (tip diameter, 2 ¢tm). GTP and GTPyS were microin- 
jected into neuron B5 at a concentration f 2 mM in a solution of (in 
mM): 60 KCI, 0.2 EGTA and 10 HEPES, pH 7.3. Typically microin- 
jection of guanine nucleotides required one injection pulse (3~50 ms) 
at 15 PSI. 
Peptide stock solutions were prepared at 10 mg/ml in a solution of 
(in raM): 50 KCI, 5 EGTA and 10 HEPES. To facilitate microinjection 
the stock solutions of peptides were diluted 3.3 mg/ml with a solution 
of (in mM): 50 KC1 and 10 HEPES. Flourescein was added to the 
injection solution to permit calibration of the volume of the electrode 
solution injected and thus the concentration f peptide in the presyn- 
aptic cell. The single letter amino acid code of peptides injected are: 
rab3AL(33~8) VSALGIDFKVKTIYRN; rab3(29-48) TPAFVSTV- 
G1DFKVKTIYRN, and ral EPTKADSYRKKVVLD. 
2.4. Chemicals 
GTP and GTPTS lithium salts were obtained from Boehringer 
Mannheim Biochemicals. Fura-2 was obtained from molecular probes 
and synthetic peptides were provided by W. Balch. 
All data are presented as mean + S.E.M. Student's t-test was used 
to assess tatistical significance. 
3. RESULTS 
To exper imenta l ly  per turb  synapt ic  proteins it is nec- 
essary to have local access to the presynapt ic  terminal .  
To achieve this end we constructed a chemical  synapse 
between pairs of  spherical neurons  B5 and VD4 as pre- 
v iously described for other Helisoma synapses [18,19]. 
Neurons  were plated together in a non-adhes ive  culture 
env i ronment  where soma-soma adhesion was main -  
ta ined in the absence of  neur i te extension or adhesion 
to the culture. In  this conf igurat ion somata  formed 
chemical  synapses with similar propert ies to the synapse 
which forms between eurites of  the same cell types [20]. 
Act ion  potent ia ls  in B5 evoked 1 for 1 inh ib i tory  
postsynapt ic  urrents  ( IPSCs) in neuron  VD4 which 
were b locked by removing external  calc ium from the 
bath ing  med ium and were reduced in ampl i tude by ad- 
d i t ion of  the chol inergic antagonist ,  tubocurar ine  chlo- 
ride (10 mM;  not  shown). At  a postsynapt ic  ho ld ing 
potent ia l  o f -80  mV and with elevated CI concentra-  
t ion (50 mM)  of  the postsynapt ic  recording solut ion,  
IPSCs are detected as inward currents in neuron  VD4. 
3.1. GTPyS augments miniature frequency but depresses 
evoked release of transmitter 
GTPzS ,  the non-hydro lyzab le  analog of  GTP,  was 
micro in jected into the presynapt ic  ell to irreversibly 
activate the cell's G proteins which include heterot-  
r imeric G proteins and small GTP-b ind ing  proteins.  
The effects of  GTPyS  on synapt ic  t ransmiss ion were 
complex and dependent  on synapt ic  act ivat ion (Fig. 1). 
Init ial ly, the act ion of  GTPyS  was mon i to red  by meas- 
ur ing the f requency of  spontaneous  min ia ture  inhib-  
i tory synapt ic  currents (MIPSCs)  in the absence of  pre- 
synapt ic  act ion potentials.  M IPSC frequency was re- 
corded for a contro l  per iod of  3 min  and  all values were 
normal ized to the mean MIPSC frequency dur ing  the 
contro l  period. Micro in ject ion of  GTPyS  in these exper- 
iments  caused a small  reduct ion in the f requency of 
spontaneous  MIPSCs ,  as previously reported [8] (Fig. 
1A) f rom a contro l  value of  1.0 to 0.69 + 0.23 (n = 9) 
with in 6 min  after injection. Previous studies indicate 
that this act ion is l ikely to involve the act ivat ion of  
heterotr imeric,  pertussis toxin-sensit ive (PTX)  G pro-  
teins which have been demonst ra ted  to reduce the secre- 
tory response to internal  ca lc ium [8]. 
When GTPyS was micro in jected into synapses while 
evoking presynapt ic  act ion potent ia ls  at intervals of  30 
s to 1 min  the frequency of  M IPSCs  increased. Three 
minutes  fo l lowing GTPyS in ject ion MIPSC frequency 
increased greater than  two-fold (Fig. 1A; n = 6). This 
elevated MIPSC frequency is signif icantly greater than 
the MIPSC f requency detected when GTP  (P < 0.01; 
n = 6) was injected into synapses or when GTPyS was 
injected into unst imulated  synapses (Fig. 1A; P < 0.01; 
n = 9). 
Whi le GTPyS enhanced MIPSC frequency, the mag- 
n i tude of  act ion potent ia l  evoked IPSCs in the same 
synapses was decreased (Fig. 1B). GTP- in jec t ion  did 
not  signif icantly modi fy  the ampl i tude of  evoked IPSCs 
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Fig. 1. GTPyS has multiple actions on synaptic transmission. Syn- 
apses were microinjected with either GTPT/S or GTP and the effects 
on MIPSC frequency (A) or action potential evoked synaptic trans- 
mission (B) were monitored. (A) GTPyS causes a small reduction in 
MIPSC frequency when injected into resting synapses. However, when 
injected into active synapses, GTPyS causes an acceleration ofMIPSC 
frequency. GTP injection in active synapses does not affect MIPSC 
frequency. (B) GTPyS injection reduces the magnitude of the action 
potential evoked synaptic urrent while GTP has no significant effect. 
(Fig. 1B). While at apparent odds with the action of 
GTP?'S on MIPSC frequency, this result is expected 
since PTX-sensitive G proteins are known to reduce 
calcium influx in synapses formed by neuron B5 [8]. 
These data reveal a conditional action of GTP?'S on 
MIPSC frequency which requires imultaneous presyn- 
aptic action potentials and the presentation of GTPyS. 
3.2. Rab3 peptides electively increase the frequency of 
MIPSCs without affecting action potential evoked 
release of transmitter 
To test whether the GTPyS-induced increase in 
MIPSC frequency might be mediated through rab-like 
GTP-binding proteins we determined the effects of syn- 
thetic peptides on synaptic transmission. Peptides with 
sequences panning the putative effector domain of 
rab3A were microinjected into the presynaptic neuron 
B5 while MIPSC frequency and action potential-evoked 
synaptic transmission were monitored. Initially a 16 
amino acid peptide rab3AL(33-48) was microinjected. 
This peptide corresponded to the amino acid residues 
3348 of the putative ffector domain but contained two 
amino acid substitutions, A and L, at positions 35 and 
36. Previous studies have demonstrated that this is a 
potent peptide for perturbing rab function [11]. Fig. 2 
shows the effect of rab3AL(3348) on MIPSC fre- 
quency. Within minutes after microinjection of 
rab3AL(3348) MIPSC frequency increased greater 
than two-fold. This increased MIPSC frequency was 
not accompanied by a significant change in unitary am- 
plitude of the MIPSCs. Fig. 2C shows amplitude distri- 
butions of MIPSCs shown in Fig. 2B. Prior to peptide 
injection, the MIPSCs have a mean amplitude of 15 pA. 
Following rab3AL(3348) injection, the number of 
MIPSCs detected at this amplitude increased, and 
events twice the unitary amplitude were recorded, pre- 
sumably because of the synchronous release of two 
quanta. Pharmacologically, MIPSCs were similar be- 
fore and after peptide injection since the cholinergic 
antagonist tubocurarine was demonstrated to reduce 
the magnitude of MIPSCs in uninjected control prepa- 
rations as well as following injection of the peptide 
rab3AL(33M8). 
The augmentation of MIPSC frequency is dose-de- 
pendent (Fig. 3A). Over the range of rab3AL(33-48) 
concentrations tested (0-60 mM), the maximal MIPSC 
frequency increase was three-fold the pre-injection level. 
In contrast o the stimulatory action on spontaneous 
MIPSC frequency, rab3AL(33~48) did not significantly 
change the magnitude of action potential evoked IPSCs 
(Fig. 3B). Thus, the peptide rab3AL(3348) selectively 
augments MIPSC frequency without affecting the am- 
plitude of evoked IPSCs. 
Rab3AL(33M8) might increase MIPSC frequency 
through actions on internal calcium or on the secretory 
machinery. To determine whether peptide injection 
caused a detectable increase in presynaptic resting cal- 
cium, B5 somata were injected with Fura-2 and the 
subsequent actions of rab3AL(33M8) were determined. 
Fura-2 was pressure injected into B5 somata to yield a 
final concentration of about 100 /IM. Neurons were 
then re-impaled with a second electrode which con- 
tained rab3AL(33-48). Rab3AL(33M8) injection 
caused a small insignificant reduction in resting calcium 
levels of -4 + 8 nM (n -- 4). While significant elevations 
of internal calcium were not detected using Fura-2 it is 
possible that rab3AL(33~8) caused a tonic calcium in- 
flux that was restricted to a sub-plasma membrane do- 
main and was undetected by Fura-2. To test for this 
possibility, synapses were recorded from, peptide was 
injected to augment MIPSC frequency and then exter- 
nal saline was changed to a high Mg2+/zero Ca 2+ saline. 
When external calcium was removed from the bathing 
medium, action potential evoked synaptic transmission 
was immediately blocked without a simultaneous reduc- 
tion in the enhanced MIPSC frequency (n = 2). Thus, 
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Fig. 2. Microinjection of rab3AL(33~8) accelerates the frequency of MIPSCs. (A) shows the frequency of MIPSC in a single preparation. At the 
arrow, rab3AL(33-48) injection caused an rapid increase in MIPSC frequency which was sustained for the period of recording. (B) shows examples 
of the MIPSCs recorded before (B,) and after rab3AL(3348) injection (Bz). (C) Shows amplitude distribution histograms for the MIPSCs before 
(C,) and following (C2) rab3AL(33~8) injection. Arrow (CO denotes the mean amplitude of MIPSCs during the recording period, and in C2 the 
two arrows mark the amplitudes of1 and 2 quanta derived from the data prior to peptide injection. Recordings were made from postsynaptic neuron 
VD4 in the whole cell configuration (Vhom --80 mV; see section 2). Calibration in B: 20 pA and 1 s. 
these data support the notion that rab3AL(3348)  di- 
rectly regulates the secretory process to increase MIPSC 
frequency. 
To test the specificity of  rab3AL(33~8) ,  other syn- 
thetic peptides were microinjected into the presynaptic 
neuron. The low solubility of  many of  the tab peptides 
prevented us from testing a variety of  different peptide 
sequences. However, two additional peptides were suc- 
cessfully used. The first of  these peptides, ral, is a mem- 
ber of  the ras superfamily of  small G proteins and has 
little homology with the putative effector domain of  
rab3A. Microinjection of  ral did not significantly affect 
MIPSC frequency or the magnitude of action potential 
evoked IPSCs (Fig. 4A). A second peptide rab3(29~8) 
which spans the putative effector domain of  rab3A and 
contains no amino acid substitutions caused an increase 
in MIPSC frequency similar to that seen with 
rab3AL(33~48). Over the concentration range 2040 
mM the increase in MIPSC frequency in response to 
rab3(29~8) was 2.6 + 0.62 (mean + S.E.M; n = 8) 
compared to 2.6 + 0.61 (n = 7) for rab3AL(33~8)  and 
0.82 + 0.18 (n = 7) for ral (Fig. 4A). MIPSC frequencies 
were significantly elevated following rab3AL(3348)  
(P < 0.02) and rab3(29-38) (P < 0.02) injection as com- 
pared to ral injection. Over the same concentration 
range there were minor effects of  peptides on evoked 
IPSC amplitude. IPSC was moderately increased to 
1.15 + 0.29 (n = 5) following rab3AL(33~8)  injection, 
to 1.6 + 0.29 (n = 7) when rab3(29~8) was injected, 
and to 1.15 + 0.2 (n = 4) following injection ofra l  (Fig. 
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Fig. 3. Rab3AL(33~48) causes a dose-dependent i crease in MIPSC 
frequency (A) while having no significant effect on the magnitude of 
evoked IPSCs in the same preparations (B). 
4B). These data demonstrate that rab peptides pecifically 
increase the basal frequency of exocytosis and have little 
effect on action potential evoked transmission. 
We demonstrated that the stimulatory action of 
GTPyS on MIPSC frequency required activity in the 
presynaptic neuron (Fig. 1). We therefore asked 
whether the stimulatory effect of rab3AL(33-48) on 
MIPSCs similarly required synaptic activity. The spon- 
taneous frequency of MIPSCs was monitored while hy- 
perpolarizing current was injected presynaptically to 
prevent he discharge of action potentials. Microinjec- 
tion of rab3AL(3348) reliably caused an increase in 
frequency of MIPSC even in the absence of presynaptic 
action potentials. Rab3AL(33-48) (2040 ¢tM) in- 
creased MIPSC frequency from a normalized control 
frequency of 1.04.04 + 2.67 within minutes ofmicroin- 
jection. This increase in MIPSCs was indistinguishable 
from the action of this peptide on MIPSCs when pre- 
synaptic activity was present. Thus, in contrast o our 
observations with GTPyS, rab3AL(3348) is able to 
increase MIPSC frequency independent of presynaptic 
action potentials. 
4. DISCUSSION 
By microinjecting two classes of molecules into the 
presynaptic terminal this study has demonstrated roles 
for G proteins in regulating synaptic transmission. 
Using the non-selective G protein activator, GTPyS, we 
have demonstrated conditional roles for G proteins in 
the synapse. In the absence ofpresynaptic action poten- 
tials, GTPg S, reduces MIPSC frequency, an action that 
is mediated by heterotrimeric G proteins and underlies 
a FMRFamide dependent presynaptic nhibition of syn- 
aptic transmission [8]. However, when the synapse is in 
use, due to presynaptic action potentials, GTPg S has 
an opposing effect and increases MIPSC frequency. 
This conditional effect may be due to calcium entry 
during the action potential, or because of a G protein 
dependent effect on vesicle mobilization and/or vesicle 
docking. 
Other experimental perturbations of synapses with 
guanine nucleotides have produced complementary 
data to those described in this study. Hess et al. [10] 
have shown in the squid giant synapse and Baux et al. 
[9] have shown in Aplysia that GTPyS injection reduces 
action potential-evoked synaptic transmission. Similar 
actions are observed in Helisoma synapses. In Helisoma 
and Aplysia this effect can be accounted for by GTPIgS 
activating heterotrimeric G proteins which regulate cal- 
cium influx and the secretory response to internal cal- 
cium [8]. However, in squid, GDPflS also reduces yn- 
aptic transmission suggesting the involvement of small 
G proteins in this effect [10]. Since miniature synaptic 
potentials were not monitored in the squid it is unclear 
whether GTPyS was able to have a similar stimulatory 
effect on basal release of neurotransmitter. 
Since GTPyS generally activates GTP-binding pro- 
teins and causes multiple effects in the synapse we used 
peptides which perturb rab GTP-binding pathways to 
examine their role in the synapse rather than pursuing 
the further use of other guanine nucleotide analogs. 
Microinjection of rab peptides selectively increased 
MIPSC frequency without changing action potential- 
evoked IPSC magnitude. The action of peptides was 
sequence specific. Injection of the putative ffector do- 
main of ral did not augment MIPSC frequency. Since 
the rab3 effector domain is similar to the effector do- 
mains of other rab proteins our data do not discriminate 
between potential perturbations to other rab systems. 
Taken together with the extensive data demonstrating 
the presence and regulation of rab3A in synapses, our 
microinjection perturbation experiments provide exper- 
imental support for the hypothesis that rab proteins 
play regulatory roles in the synapse. However, further 
experiments are required to determine the precise role 
of these proteins. 
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Fig. 4. Rab peptides electively increase MIPSC frequency. Three 
different peptides were injected presynaptically into synapses. 
Rab3AL(33~8) and rab3(29~8) stimulate an increased frequency of 
MIPSCs while a ral peptide, with little sequence homology with the 
rab effector domain, does not significantly affect MIPSC frequency 
(A). In contrast o the stimulatory actions of rab peptides on MIPSC 
frequency, rab3AL(33~8) and rab3(29 38) have modest actions on 
the magnitude ofthe action potential evoked IPSC. 
The stimulatory mechanism of rab peptide action in 
secretion [12 14] is not defined. By analogy with ras- 
GAP one explanation is that the peptides prevent rab- 
GAP interaction and thus reduce rab hydrolysis of 
GTP. Alternatively, the rab peptides may directly inter- 
act with a rab-effector protein (REP) to promote a stim- 
ulatory action. Studies by Oberhauser et al. [12] support 
the possibility that peptides timulate a REP since the 
action of rab peptides is enhanced in mast cells when 
GTP is dialyzed out of the cell, or when GDPbS is 
added to the cell. 
There are many explanations for the differential ef- 
fects of rab peptides on MIPSC frequency and action 
potential evoked transmitter release. (1) Rab peptides 
might stimulate a calcium-independent pathway of 
quantal neurotransmitter r lease that is parallel to cal- 
cium regulated release. (2) Perhaps the exocytosis of 
vesicles that are distant from calcium channels is being 
stimulated by rab peptides. (3) Alternatively the peptide 
might act on an effector protein which responds to mul- 
tiple stimuli including calcium and the rab effector do- 
main. In this scenario, a differential action on MIPSC 
frequency and evoked transmission would require that 
rab peptide and calcium signals for exocytosis were inte- 
grated in an additive manner by a common macromol- 
ecular complex. Under conditions of low internal cal- 
cium, in resting synapses, rab peptides could signifi- 
cantly increase the frequency of basal exocytosis. How- 
ever, during a large calcium stimulus such as supplied 
by the action potential, the action of rab peptide would 
be small, and undetectable by comparison to the cal- 
cium-stimulus. 
A comparison of the effects of GTPyS and rab pep- 
tides on transmitter release is difficult because GTPyS 
activates many GTP-binding proteins simultaneously. 
However, an important observation with the GTPyS 
injection experiments i  that both GTPyS and presyn- 
aptic action potentials are required to promote the in- 
creased frequency of MIPSCs. While this may be due 
to an interaction between calcium entry during action 
potentials and GTPyS, it is also possible that it is re- 
lated to the recruitment of a vesicle associated GTP- 
binding protein, such as rab3A, during vesicle cycling. 
A difference between the GTPyS and rab peptide data 
is that the peptides are able to increase MIPSC fre- 
quency in the absence of presynaptic action potentials 
while GTPyS is not. This might be expected since a 
peptide may have ready access to the REP while GTPyS 
might not since GTPyS would only act at this site when 
associated with the rab3 protein and associated vesicle. 
In conclusion, our data demonstrate hat rab3A pep- 
tides with sequences spanning the putative ffector do- 
main of this protein cause a significant stimulation of 
basal release of neurotransmitter. However, action po- 
tential evoked release of neurotransmitter is unaffected 
by the same peptides. Similar differential effects on 
MIPSC frequency and action potential evoked synaptic 
transmission were also detected following microinjec- 
tion of the non-hydrolyzable analog of GTR GTPyS. 
These data provide experimental data in support of a 
role for the small GTP-binding protein rab3A in the 
regulation of the synapse. 
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